Showing 15 posts of 52 posts found.

Cow in field

Global animal health market set to be worth $44.2 billion by 2020

July 5, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, agriculture, animal, health, meat, pharma

The global animal health market is predicted to reach a value of $44.2 billion dollars by 2020, according to analysts …


Nabriva closes in on bringing new class of antibiotic to market

May 22, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical

Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could …


EMA announces second-ever public hearing on high-use antibiotics

April 12, 2018
Medical Communications Antibiotics, EMA, biotech, drugs, pharma, pharmaceutical

The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding …


64% of FDC antibiotics in India are unapproved, report reveals

February 5, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, India, antimicrobial resistance, pharma

The majority of fixed dose combination (FDC) antibiotics that are made and sold in India are still unapproved, despite promises …


NICE urges curbing the use of antibiotics for sore throats

January 26, 2018
Medical Communications Antibiotics, NICE, biotech, drugs, pharma, pharmaceutical

In a study published by the BMJ a few years ago, it was found that antibiotics were prescribed in 60% …


Public Health England sounds warning against overuse of antibiotics

October 23, 2017
Medical Communications, Sales and Marketing Antibiotics, biotech, drugs, pharma, pharmaceutical

Public Health England (PHE) has unveiled the findings from its English surveillance programme for antimicrobial utilisation and resistance report, suggesting …


Roche launches Warp Drive antibiotic collaboration for $387m

October 16, 2017
Sales and Marketing Antibiotics, Roche, biotech, drugs, pharma, pharmaceutical

Roche had tentatively begun to re-enter the antibiotic space, but it has now signalled its growing intention to move in …


Study contradicts widely held belief on length of antibiotics use

July 27, 2017
Medical Communications, Research and Development Antibiotics, antibiotic resistance, biotech, drugs, pharma, pharmaceutical

If you’ve ever taken a course of antibiotics then you will be familiar with the piece of advice that is …


FDA-approved drugs in combination could provide new antibiotics

June 21, 2017
Research and Development Antibiotics, FDA, antibiotic resistance

Research emerging from the University of Utah Health has built on knowledge that drugs used in combination can be more …


Superbugs in the supply chain

May 26, 2017
Medical Communications Antibiotics, Changing Markets, China, IMAGE: Changing Markets, Superbugs

Bad Manufacturing Practices: Changing Markets examines China’s role in the antibiotics supply chain and the damaging pollution that results from …


Antibiotics found to fail in quarter of pneumonia patients

May 24, 2017
Research and Development Antibiotics, antibiotic resistance, pneumonia

A new study that emerged from the 2017 American Thoracic Society International Conference revealed that 22.1% of patients who were …


Komodo dragon blood could hold secret to new antibiotic

April 12, 2017
Research and Development Antibiotics, Komodo dragon, antibiotic resistance

The urgency to find new antibiotics has led researchers into the mouths of Komodo dragons. In particular, the researchers were …


FDA steps up fight against superbugs with livestock ruling

January 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, FDA, Guidelines, Livestock, agriculture, antibiotic resistance, farmers

The FDA began the year by announcing the implementation of ‘Guidance for Industry #213’. The new rule is a voluntary …

AstraZeneca’s Zavicefta meets primary endpoint in Phase III pneumonia trials

July 21, 2016
Research and Development Antibiotics, AstraZeneca, zavifecta

AstraZeneca has announced results from a Phase III trial for its recently approved antibiotic, Zavicefta (ceftazidime-avibactam), which met its primary …

Latest content